关于DDT的问题

G L Ross

Lancet (London, England)

|October 13, 2000

概括

No abstract available in PubMed .

相关概念视频

您也可能阅读

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Clinical significance of intra-nodal naevi in sentinel node biopsies for malignant melanoma.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2016

Same author

Attitudes to contralateral risk reducing mastectomy among breast and plastic surgeons in England.

Annals of the Royal College of Surgeons of England·2016

Same author

The Manchester guidelines for contralateral risk-reducing mastectomy.

World journal of surgical oncology·2015

Same author

Contralateral risk-reducing mastectomy: review of risk factors and risk-reducing strategies.

International journal of surgical oncology·2015

Same author

Challenges and new horizons in the management of advanced basal cell carcinoma: a UK perspective.

British journal of cancer·2014

Same author

Mastectomies of healthy, contralateral breasts in patients with breast cancer.

British journal of hospital medicine (London, England : 2005)·2013

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

查看所有相关文章

相关实验视频

关于DDT的问题

相关概念视频

Clinical significance of intra-nodal naevi in sentinel node biopsies for malignant melanoma.

Attitudes to contralateral risk reducing mastectomy among breast and plastic surgeons in England.

The Manchester guidelines for contralateral risk-reducing mastectomy.

Contralateral risk-reducing mastectomy: review of risk factors and risk-reducing strategies.

Challenges and new horizons in the management of advanced basal cell carcinoma: a UK perspective.

Mastectomies of healthy, contralateral breasts in patients with breast cancer.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

关于DDT的问题

相关概念视频

Clinical significance of intra-nodal naevi in sentinel node biopsies for malignant melanoma.

Attitudes to contralateral risk reducing mastectomy among breast and plastic surgeons in England.

The Manchester guidelines for contralateral risk-reducing mastectomy.

Contralateral risk-reducing mastectomy: review of risk factors and risk-reducing strategies.

Challenges and new horizons in the management of advanced basal cell carcinoma: a UK perspective.

Mastectomies of healthy, contralateral breasts in patients with breast cancer.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.